866-997-4948(US-Canada Toll Free)

Global Cholesterol Lowering Biologic Drugs Market Professional Survey Report 2019

Published By :

QYResearch

Published Date : Oct 2019

Category :

Pharmaceutical

No. of Pages : 104 Pages

The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the countrys population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.

The global Cholesterol Lowering Biologic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cholesterol Lowering Biologic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cholesterol Lowering Biologic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cholesterol Lowering Biologic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cholesterol Lowering Biologic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
For Oral Administration
Injectable Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
Table of Contents

Executive Summary
1 Industry Overview of Cholesterol Lowering Biologic Drugs
1.1 Definition of Cholesterol Lowering Biologic Drugs
1.2 Cholesterol Lowering Biologic Drugs Segment by Type
1.2.1 Global Cholesterol Lowering Biologic Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 For Oral Administration
1.2.3 Injectable Drugs
1.3 Cholesterol Lowering Biologic Drugs Segment by Applications
1.3.1 Global Cholesterol Lowering Biologic Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Global Cholesterol Lowering Biologic Drugs Overall Market
1.4.1 Global Cholesterol Lowering Biologic Drugs Revenue (2014-2025)
1.4.2 Global Cholesterol Lowering Biologic Drugs Production (2014-2025)
1.4.3 North America Cholesterol Lowering Biologic Drugs Status and Prospect (2014-2025)
1.4.4 Europe Cholesterol Lowering Biologic Drugs Status and Prospect (2014-2025)
1.4.5 China Cholesterol Lowering Biologic Drugs Status and Prospect (2014-2025)
1.4.6 Japan Cholesterol Lowering Biologic Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cholesterol Lowering Biologic Drugs Status and Prospect (2014-2025)
1.4.8 India Cholesterol Lowering Biologic Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cholesterol Lowering Biologic Drugs
2.3 Manufacturing Process Analysis of Cholesterol Lowering Biologic Drugs
2.4 Industry Chain Structure of Cholesterol Lowering Biologic Drugs

3 Development and Manufacturing Plants Analysis of Cholesterol Lowering Biologic Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Cholesterol Lowering Biologic Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cholesterol Lowering Biologic Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cholesterol Lowering Biologic Drugs Production and Capacity Analysis
4.2 Cholesterol Lowering Biologic Drugs Revenue Analysis
4.3 Cholesterol Lowering Biologic Drugs Price Analysis
4.4 Market Concentration Degree

5 Cholesterol Lowering Biologic Drugs Regional Market Analysis
5.1 Cholesterol Lowering Biologic Drugs Production by Regions
5.1.1 Global Cholesterol Lowering Biologic Drugs Production by Regions
5.1.2 Global Cholesterol Lowering Biologic Drugs Revenue by Regions
5.2 Cholesterol Lowering Biologic Drugs Consumption by Regions
5.3 North America Cholesterol Lowering Biologic Drugs Market Analysis
5.3.1 North America Cholesterol Lowering Biologic Drugs Production
5.3.2 North America Cholesterol Lowering Biologic Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cholesterol Lowering Biologic Drugs Import and Export
5.4 Europe Cholesterol Lowering Biologic Drugs Market Analysis
5.4.1 Europe Cholesterol Lowering Biologic Drugs Production
5.4.2 Europe Cholesterol Lowering Biologic Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cholesterol Lowering Biologic Drugs Import and Export
5.5 China Cholesterol Lowering Biologic Drugs Market Analysis
5.5.1 China Cholesterol Lowering Biologic Drugs Production
5.5.2 China Cholesterol Lowering Biologic Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cholesterol Lowering Biologic Drugs Import and Export
5.6 Japan Cholesterol Lowering Biologic Drugs Market Analysis
5.6.1 Japan Cholesterol Lowering Biologic Drugs Production
5.6.2 Japan Cholesterol Lowering Biologic Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cholesterol Lowering Biologic Drugs Import and Export
5.7 Southeast Asia Cholesterol Lowering Biologic Drugs Market Analysis
5.7.1 Southeast Asia Cholesterol Lowering Biologic Drugs Production
5.7.2 Southeast Asia Cholesterol Lowering Biologic Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cholesterol Lowering Biologic Drugs Import and Export
5.8 India Cholesterol Lowering Biologic Drugs Market Analysis
5.8.1 India Cholesterol Lowering Biologic Drugs Production
5.8.2 India Cholesterol Lowering Biologic Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cholesterol Lowering Biologic Drugs Import and Export

6 Cholesterol Lowering Biologic Drugs Segment Market Analysis (by Type)
6.1 Global Cholesterol Lowering Biologic Drugs Production by Type
6.2 Global Cholesterol Lowering Biologic Drugs Revenue by Type
6.3 Cholesterol Lowering Biologic Drugs Price by Type

7 Cholesterol Lowering Biologic Drugs Segment Market Analysis (by Application)
7.1 Global Cholesterol Lowering Biologic Drugs Consumption by Application
7.2 Global Cholesterol Lowering Biologic Drugs Consumption Market Share by Application (2014-2019)

8 Cholesterol Lowering Biologic Drugs Major Manufacturers Analysis
8.1 Amgen
8.1.1 Amgen Cholesterol Lowering Biologic Drugs Production Sites and Area Served
8.1.2 Amgen Product Introduction, Application and Specification
8.1.3 Amgen Cholesterol Lowering Biologic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Regeneron Pharmaceuticals
8.2.1 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Sites and Area Served
8.2.2 Regeneron Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Alnylam Pharmaceuticals
8.3.1 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Sites and Area Served
8.3.2 Alnylam Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served

9 Development Trend of Analysis of Cholesterol Lowering Biologic Drugs Market
9.1 Global Cholesterol Lowering Biologic Drugs Market Trend Analysis
9.1.1 Global Cholesterol Lowering Biologic Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Cholesterol Lowering Biologic Drugs Regional Market Trend
9.2.1 North America Cholesterol Lowering Biologic Drugs Forecast 2019-2025
9.2.2 Europe Cholesterol Lowering Biologic Drugs Forecast 2019-2025
9.2.3 China Cholesterol Lowering Biologic Drugs Forecast 2019-2025
9.2.4 Japan Cholesterol Lowering Biologic Drugs Forecast 2019-2025
9.2.5 Southeast Asia Cholesterol Lowering Biologic Drugs Forecast 2019-2025
9.2.6 India Cholesterol Lowering Biologic Drugs Forecast 2019-2025
9.3 Cholesterol Lowering Biologic Drugs Market Trend (Product Type)
9.4 Cholesterol Lowering Biologic Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cholesterol Lowering Biologic Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table

List of Tables and Figures
Figure Picture of Cholesterol Lowering Biologic Drugs
Table Global Cholesterol Lowering Biologic Drugs Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Cholesterol Lowering Biologic Drugs Production Market Share by Types in 2018
Figure For Oral Administration Product Picture
Figure Injectable Drugs Product Picture
Table Global Cholesterol Lowering Biologic Drugs Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Cholesterol Lowering Biologic Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Drug Stores
Figure Online Sales
Figure Global Cholesterol Lowering Biologic Drugs Revenue (Million USD) (2014-2025)
Figure Global Cholesterol Lowering Biologic Drugs Production (K MT) (2014-2025)
Figure North America Cholesterol Lowering Biologic Drugs Market Size (Million USD) (2014-2025)
Figure Europe Cholesterol Lowering Biologic Drugs Market Size (Million USD) (2014-2025)
Figure China Cholesterol Lowering Biologic Drugs Market Size (Million USD) (2014-2025)
Figure Japan Cholesterol Lowering Biologic Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cholesterol Lowering Biologic Drugs Market Size (Million USD) (2014-2025)
Figure India Cholesterol Lowering Biologic Drugs Market Size (Million USD) (2014-2025)
Table Cholesterol Lowering Biologic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cholesterol Lowering Biologic Drugs in 2018
Figure Manufacturing Process Analysis of Cholesterol Lowering Biologic Drugs
Figure Industry Chain Structure of Cholesterol Lowering Biologic Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cholesterol Lowering Biologic Drugs Manufacturing Plants Distribution
Table Cholesterol Lowering Biologic Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cholesterol Lowering Biologic Drugs Capacity (K MT) of Major Manufacturers (2014-2019)
Table Cholesterol Lowering Biologic Drugs Production (K MT) of Major Manufacturers (2014-2019)
Table Cholesterol Lowering Biologic Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Cholesterol Lowering Biologic Drugs Production Share by Manufacturers in 2018
Table Cholesterol Lowering Biologic Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cholesterol Lowering Biologic Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers in 2018
Table Cholesterol Lowering Biologic Drugs Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cholesterol Lowering Biologic Drugs Production by Regions 2014-2019 (K MT)
Table Global Cholesterol Lowering Biologic Drugs Production Market Share by Regions 2014-2019
Figure Global Cholesterol Lowering Biologic Drugs Production Market Share by Regions in 2018
Table Global Cholesterol Lowering Biologic Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Regions in 2018
Table Global Cholesterol Lowering Biologic Drugs Consumption by Regions 2014-2019 (K MT)
Table Global Cholesterol Lowering Biologic Drugs Consumption Market Share by Regions 2014-2019
Figure North America Cholesterol Lowering Biologic Drugs Production Growth Rate 2014-2019 (K MT)
Figure North America Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cholesterol Lowering Biologic Drugs Production, Consumption Import and Export (K MT)
Figure Europe Cholesterol Lowering Biologic Drugs Production Growth Rate 2014-2019 (K MT)
Figure Europe Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cholesterol Lowering Biologic Drugs Production, Consumption Import and Export (K MT)
Figure China Cholesterol Lowering Biologic Drugs Production Growth Rate 2014-2019 (K MT)
Figure China Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Cholesterol Lowering Biologic Drugs Production, Consumption Import and Export (K MT)
Figure Japan Cholesterol Lowering Biologic Drugs Production Growth Rate 2014-2019 (K MT)
Figure Japan Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cholesterol Lowering Biologic Drugs Production, Consumption Import and Export (K MT)
Figure Southeast Asia Cholesterol Lowering Biologic Drugs Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cholesterol Lowering Biologic Drugs Production, Consumption Import and Export (K MT)
Figure India Cholesterol Lowering Biologic Drugs Production Growth Rate 2014-2019 (K MT)
Figure India Cholesterol Lowering Biologic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Cholesterol Lowering Biologic Drugs Production, Consumption Import and Export (K MT)
Figure Global Consumption Cholesterol Lowering Biologic Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cholesterol Lowering Biologic Drugs Market Share by Application (2014-2019)
Table Amgen Cholesterol Lowering Biologic Drugs Production Sites and Area Served
Table Amgen Cholesterol Lowering Biologic Drugs Product Introduction, Application and Specification
Table Amgen Cholesterol Lowering Biologic Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
Table Amgen Cholesterol Lowering Biologic Drugs Production Market Share (2014-2019)
Figure Amgen Cholesterol Lowering Biologic Drugs Revenue Market Share (2014-2019)
Table Amgen Cholesterol Lowering Biologic Drugs Main Business and Markets Served
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Sites and Area Served
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Introduction, Application and Specification
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Market Share (2014-2019)
Figure Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Revenue Market Share (2014-2019)
Table Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Main Business and Markets Served
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Sites and Area Served
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Product Introduction, Application and Specification
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Market Share (2014-2019)
Figure Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Revenue Market Share (2014-2019)
Table Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Main Business and Markets Served
Figure Global Cholesterol Lowering Biologic Drugs Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Cholesterol Lowering Biologic Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cholesterol Lowering Biologic Drugs Sales Price (USD/MT) Forecast 2019-2025
Figure North America Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Cholesterol Lowering Biologic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Cholesterol Lowering Biologic Drugs by Type (2019-2025)
Table Global Consumption (K MT) of Cholesterol Lowering Biologic Drugs by Application (2019-2025)
Table Cholesterol Lowering Biologic Drugs Distributors List
Table Cholesterol Lowering Biologic Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *